


Ask a doctor about a prescription for CARVEDILOL SANDOZ 6.25 mg TABLETS
Package Leaflet: Information for the User
Carvedilol Sandoz 6.25 mg Tablets EFG
Carvedilol Sandoz 25 mg Tablets EFG
carvedilol
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.Keep this leaflet. You may need to read it again.
Contents of the pack and other information
Carvedilol Sandoz contains carvedilol as the active substance, which belongs to a group of medicines known as alpha and beta receptor blockers. Carvedilol has antioxidant, antihypertensive (reducing blood pressure), vasodilating, and anti-anginal properties. It also reduces cardiac output and has beneficial effects on blood circulation at the heart level. Carvedilol is indicated for the treatment of:
Note on use in chronic heart failure:
Do not take Carvedilol Sandoz:
When carvedilol is administered at the same time as certain medications, such as adrenaline (also epinephrine) to treat allergic reactions (anaphylactic), special caution is required. It is possible that they may respond less to these. Inform your doctor immediately if you have these diseases or circumstances that accompany them, as they must be taken into account before or during treatment.
Withdrawal symptoms (withdrawal syndrome)
Treatment with carvedilol should not be interrupted suddenly. This is especially true in patients with heart disease due to the reduction of blood flow to the coronary arteries. Instead, the dose should be gradually reduced over a period of 2 weeks.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Carvedilol Sandoz.
Inform your doctor if you have any of the following diseases:
As with all medications with beta-blocking activity, treatment with carvedilol should not be interrupted abruptly. The dose should be gradually reduced according to your doctor's instructions.
Use in athletes
Athletes are informed that this medication contains a component that may result in a positive doping test.
Children and adolescents
The use of carvedilol is not recommended in children and adolescents under 18 years of age due to insufficient safety and efficacy data.
Older adults
Older adults may be more sensitive to carvedilol and should be monitored more closely.
Other medications and Carvedilol Sandoz
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication, including those obtained without a prescription.
This is extremely important, as taking more than one medication at the same time can increase or decrease its effect. Therefore, you should not take carvedilol with any other medication unless your doctor indicates it. Note that these instructions may also apply to medications that have been used before or may be used after.
Inform your doctor if you are taking any of the following medications:
Taking Carvedilol Sandoz with food, drinks, and alcohol
It is recommended to avoid taking carvedilol simultaneously or immediately after taking grapefruit or grapefruit juice. Grapefruit or grapefruit juice may cause an increase in carvedilol in the blood and lead to unpredictable side effects. Excessive and simultaneous or occasional consumption of alcohol should also be avoided, as alcohol influences the effect of carvedilol.
Your doctor or pharmacist will inform you about the meals with which it is recommended to take carvedilol.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
The use of carvedilol is not recommended during pregnancy and breastfeeding.
Carvedilol may cause fetal death in the womb, as well as premature birth. Additionally, side effects may occur in the fetus and newborn. After birth, the newborn has a higher risk of heart and lung problems.
Since carvedilol is excreted in breast milk, its administration is not recommended during breastfeeding.
Driving and using machines
Occasionally, carvedilol may impair the ability to drive or operate machines. This occurs especially when starting or changing treatment and when taken together with alcohol.
Carvedilol Sandoz contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medication.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The normal dose is:
Essential hypertension
Adults
Oral. The recommended starting dose is 12.5 mg once a day for the first two days, then the recommended dose is 25 mg once a day. If necessary, your doctor may gradually increase the dose you receive (at intervals of at least two weeks) up to 50 mg once a day or in two doses of 25 mg each.
Older adults
Oral. The recommended starting dose is 12.5 mg once a day, which has provided satisfactory control in some patients. If the response is not adequate, your doctor will adjust the dose (at intervals of at least two weeks).
Ischemic heart disease
Adults
Oral. The recommended starting dose is 12.5 mg twice a day (total 25 mg per day) for the first two days. Then, the recommended dose is 25 mg twice a day (total 50 mg per day). If necessary, your doctor may increase the dose you receive (at intervals of at least two weeks) up to 50 mg twice a day (total 100 mg/day).
Older adults
Oral. The maximum recommended dose for older adults is 50 mg administered in divided doses (twice a day).
Symptomatic congestive heart failure
Adults and older adults
Oral. Your doctor will indicate the individual dose you should take, monitoring you during the adjustment to higher doses.
In case you are taking other medications for heart disease (digitalis) or blood pressure control (diuretics and/or ACE inhibitors) and before starting treatment with carvedilol, your doctor will adjust the amount of these medications you should take.
In any case, the recommended dose for starting treatment with carvedilol in the treatment of symptomatic congestive heart failure is 3.12 mg twice a day (total 6.25 mg per day) for two weeks. If you tolerate this dose well, it can be increased later (at intervals of at least two weeks) up to 6.25 mg twice a day (total 12.5 mg per day).
Your doctor may prescribe higher doses of carvedilol later (after at least two weeks).
If you weigh less than 85 kg, the maximum recommended dose is 25 mg twice a day (total 50 mg per day). If your weight is over 85 kg, the maximum recommended dose is 50 mg twice a day (100 mg per day).
Your doctor will indicate the duration of your treatment with carvedilol.
As a general rule, regardless of your disease, withdrawal of carvedilol should be done gradually over a few days, or the dose should be reduced by half every three days.
Use in children and adolescents
The use of carvedilol is not recommended in children and adolescents under 18 years of age, as there is insufficient data on safety and efficacy.
Guidelines for correct administration
The tablets should be swallowed with sufficient liquid, preferably with a glass of water.
If you have congestive heart failure (your heart has lost some of its ability to pump blood and may cause difficulty breathing, weakness, and fluid accumulation), you should take carvedilol while eating to avoid dizziness when standing up.
Remember to take your medication.
If you take more Carvedilol Sandoz than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Carvedilol Sandoz
Do not take a double dose to make up for forgotten doses.
If you stop taking Carvedilol Sandoz
Treatment with carvedilol should not be interrupted abruptly, especially if you have ischemic heart disease, a disease that causes the heart to not pump blood well. Your doctor will gradually reduce the dose over a few days until you stop taking carvedilol completely.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
The frequencies of adverse effects have been listed below according to the following definitions:
Very common (may affect more than 1 in 10 patients)
Common (may affect up to 1 in 10 patients)
Uncommon (may affect up to 1 in 100 patients)
Rare (may affect up to 1 in 1,000 patients)
Very rare (may affect up to 1 in 10,000 patients)
Frequency not known (cannot be estimated from the available data)
The adverse effects that have been observed are the following:
Infections and Infestations
Common: Bronchitis, pneumonia, upper respiratory tract infections, urinary tract infections.
Disorders of the Nervous System
Very common: Headache, dizziness, and weakness that are usually mild and occur mainly at the beginning of treatment.
Common: Presyncope, syncope (fainting), especially at the start of treatment.
Uncommon: Paresthesias (tingling sensation).
Psychiatric Disorders
Common: Depressed mood, depression.
Uncommon: Sleep disorders.
Frequency not known: Hallucinations, nightmares, confusion, psychosis.
Cardiac Disorders
Very common: Increased heart failure (the heart has lost part of its ability to pump blood).
Common: Bradycardia (decreased heart rate), fluid overload, increased blood volume in the body.
Uncommon: Atrioventricular (AV) block (heart problems), and angina pectoris (chest pain).
Frequency not known: Sinus arrest (a condition that makes the heartbeats become very slow or stop), especially in elderly patients or patients with other heart rhythm problems.
Vascular Disorders
Very common: Low blood pressure.
Common: Postural hypotension (dizziness when standing up or changing body position), peripheral circulation disorders (cold hands and feet), increased symptoms in patients with intermittent claudication (increased leg pain when walking) or Raynaud's phenomenon (decreased blood flow to the fingers and toes, ears, and nose), hypertension.
Respiratory, Thoracic, and Mediastinal Disorders
Common: Asthma and difficulty breathing in predisposed patients, fluid accumulation in the lungs.
Rare: Nasal congestion.
Gastrointestinal Disorders
Common: Gastrointestinal disorders with symptoms such as nausea, diarrhea, abdominal pain, indigestion, vomiting.
Uncommon: Constipation.
Rare: Dry mouth.
Disorders of the Skin and Subcutaneous Tissue
Uncommon: Skin reactions (e.g., allergic exanthema, dermatitis, urticaria, itching, psoriasis, lichen planus-like skin lesions).
Frequency not known: Hair loss, severe cutaneous adverse reactions (e.g., toxic epidermal necrolysis, erythema multiforme, Stevens-Johnson syndrome), excessive sweating (hyperhidrosis).
Disorders of the Blood and Lymphatic System
Common: Decreased red blood cell count (anemia).
Rare: Decreased platelet count (thrombocytopenia)
Very rare: Decreased white blood cell count (leukopenia).
Hepatobiliary Disorders
Very rare: Alterations in serum transaminases (changes in the amount of certain liver enzymes in the blood).
Eye Disorders
Common: Decreased tear production (dry eye), eye irritation, vision changes.
Renal and Urinary Disorders
Common: Acute renal failure (the kidney does not function properly) and renal function disorders in patients with diffuse vascular disease and/or altered renal function.
Rare: Urination problems.
Frequency not known: Urinary incontinence in women (disappears when stopping the medication).
Disorders of the Immune System
Very rare: Allergic reactions.
Musculoskeletal and Connective Tissue Disorders
Common: Pain in the limbs.
Disorders of the Reproductive System and Breast
Uncommon: Impotence.
Metabolic and Nutritional Disorders
Common: Worsening of blood sugar control in diabetic patients (hyperglycemia, hypoglycemia), weight gain, increased cholesterol in the blood.
Frequency not known: It is possible that latent diabetes mellitus may manifest or that existing diabetes may worsen.
General Disorders and Administration Site Conditions
Very common: Fatigue.
Common: Pain, edema (fluid retention, swelling of the legs, ankles, and feet).
If you consider that any of the adverse effects you are suffering from is serious or if you notice any adverse effect not mentioned in this prospectus, inform your doctor or pharmacist.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not store above 30°C.
Store in the original packaging to protect it from light.
Do not use this medicine after the expiration date that appears on the packaging after CAD/EXP. The expiration date is the last day of the month indicated.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Carvedilol Sandoz 6.25 mg:
Composition of Carvedilol Sandoz 25 mg:
Appearance of the Product and Package Contents
Carvedilol Sandoz 6.25 mg are round, convex tablets, yellow in color, scored on both sides, and marked with C2 on one side.
They are available in packages of 28 tablets.
Carvedilol Sandoz 25 mg are round, convex tablets, white in color, scored on both sides, and marked with C4 on one side.
They are available in packages of 28 tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Sandoz Farmacéutica, S.A. Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer:
Salutas Pharma GmbH
Otto Von Guericke Allee 1
39179 Barleben
Germany
Date of the Last Revision of this Prospectus:January 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
The average price of CARVEDILOL SANDOZ 6.25 mg TABLETS in November, 2025 is around 2.5 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for CARVEDILOL SANDOZ 6.25 mg TABLETS – subject to medical assessment and local rules.